1147 related articles for article (PubMed ID: 14962586)
21. A timely re-examination of drug polymorphism in pharmaceutical development and regulation.
Grant DJ; Byrn SR
Adv Drug Deliv Rev; 2004 Feb; 56(3):237-9. PubMed ID: 14962580
[No Abstract] [Full Text] [Related]
22. A PAT-based qualification of pharmaceutical excipients produced by batch or continuous processing.
Hertrampf A; Müller H; Menezes JC; Herdling T
J Pharm Biomed Anal; 2015 Oct; 114():208-15. PubMed ID: 26072012
[TBL] [Abstract][Full Text] [Related]
23. A Process Analytical Technology (PAT) approach to control a new API manufacturing process: development, validation and implementation.
Schaefer C; Clicq D; Lecomte C; Merschaert A; Norrant E; Fotiadu F
Talanta; 2014 Mar; 120():114-25. PubMed ID: 24468350
[TBL] [Abstract][Full Text] [Related]
24. Process analytical technology and compensating for nonlinear effects in process spectroscopic data for improved process monitoring and control.
Chen Z; Morris J
Biotechnol J; 2009 May; 4(5):610-9. PubMed ID: 19452463
[TBL] [Abstract][Full Text] [Related]
25. Prospects for multivariate classification of a pharmaceutical intermediate with near-infrared spectroscopy as a process analytical technology (PAT) production control supplement.
Märk J; Andre M; Karner M; Huck CW
Eur J Pharm Biopharm; 2010 Oct; 76(2):320-7. PubMed ID: 20600883
[TBL] [Abstract][Full Text] [Related]
26. Application of the near-infrared spectroscopy in the pharmaceutical technology.
Jamrógiewicz M
J Pharm Biomed Anal; 2012 Jul; 66():1-10. PubMed ID: 22469433
[TBL] [Abstract][Full Text] [Related]
27. Near-infrared spectroscopy and imaging: basic principles and pharmaceutical applications.
Reich G
Adv Drug Deliv Rev; 2005 Jun; 57(8):1109-43. PubMed ID: 15899537
[TBL] [Abstract][Full Text] [Related]
28. Real-time endpoint monitoring and determination for a pharmaceutical salt formation process with in-line FT-IR spectroscopy.
Lin Z; Zhou L; Mahajan A; Song S; Wang T; Ge Z; Ellison D
J Pharm Biomed Anal; 2006 Apr; 41(1):99-104. PubMed ID: 16321495
[TBL] [Abstract][Full Text] [Related]
29. Phase transformation considerations during process development and manufacture of solid oral dosage forms.
Zhang GG; Law D; Schmitt EA; Qiu Y
Adv Drug Deliv Rev; 2004 Feb; 56(3):371-90. PubMed ID: 14962587
[TBL] [Abstract][Full Text] [Related]
30. Challenges in the development of hydrate phases as active pharmaceutical ingredients--an example.
Feth MP; Nagel N; Baumgartner B; Bröckelmann M; Rigal D; Otto B; Spitzenberg M; Schulz M; Becker B; Fischer F; Petzoldt C
Eur J Pharm Sci; 2011 Jan; 42(1-2):116-29. PubMed ID: 21073949
[TBL] [Abstract][Full Text] [Related]
31. Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin.
Zhang F; Aaltonen J; Tian F; Saville DJ; Rades T
Eur J Pharm Biopharm; 2009 Jan; 71(1):64-70. PubMed ID: 18703139
[TBL] [Abstract][Full Text] [Related]
32. Nucleation of crystals from solution: classical and two-step models.
Erdemir D; Lee AY; Myerson AS
Acc Chem Res; 2009 May; 42(5):621-9. PubMed ID: 19402623
[TBL] [Abstract][Full Text] [Related]
33. Polymorph selection: the role of nucleation, crystal growth and molecular modeling.
Erdemir D; Lee AY; Myerson AS
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):746-55. PubMed ID: 17987526
[TBL] [Abstract][Full Text] [Related]
34. A quality by design study applied to an industrial pharmaceutical fluid bed granulation.
Lourenço V; Lochmann D; Reich G; Menezes JC; Herdling T; Schewitz J
Eur J Pharm Biopharm; 2012 Jun; 81(2):438-47. PubMed ID: 22446063
[TBL] [Abstract][Full Text] [Related]
35. Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy.
Heinz A; Strachan CJ; Gordon KC; Rades T
J Pharm Pharmacol; 2009 Aug; 61(8):971-88. PubMed ID: 19703341
[TBL] [Abstract][Full Text] [Related]
36. Quality control of packed raw materials in pharmaceutical industry.
Rodionova OY; Sokovikov YV; Pomerantsev AL
Anal Chim Acta; 2009 May; 642(1-2):222-7. PubMed ID: 19427480
[TBL] [Abstract][Full Text] [Related]
37. Application of on-line Raman spectroscopy for characterizing relationships between drug hydration state and tablet physical stability.
Hausman DS; Cambron RT; Sakr A
Int J Pharm; 2005 Aug; 299(1-2):19-33. PubMed ID: 15979262
[TBL] [Abstract][Full Text] [Related]
38. Self-modeling curve resolution (SMCR) analysis of near-infrared (NIR) imaging data of pharmaceutical tablets.
Awa K; Okumura T; Shinzawa H; Otsuka M; Ozaki Y
Anal Chim Acta; 2008 Jun; 619(1):81-6. PubMed ID: 18539178
[TBL] [Abstract][Full Text] [Related]
39. Process analytical applications of Raman spectroscopy.
Rantanen J
J Pharm Pharmacol; 2007 Feb; 59(2):171-7. PubMed ID: 17270071
[TBL] [Abstract][Full Text] [Related]
40. Improved understanding of factors contributing to quantification of anhydrate/hydrate powder mixtures.
Rantanen J; Wikström H; Rhea FE; Taylor LS
Appl Spectrosc; 2005 Jul; 59(7):942-51. PubMed ID: 16053567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
